Back
G1 Therapeutics Vs. Verrica Pharmaceuticals Industry Stock Comparison
Sell
46
GTHX
G1 Therapeutics
Last Price:
7.15
Seasonality Move:
-11.02%
Sell
22
VRCA
Verrica Pharmaceuticals
Last Price:
1.81
Seasonality Move:
-3.15%
Sell
46
G1 Therapeutics (GTHX)
is a Sell
Is G1 Therapeutics a Buy, Sell or Hold?
- The current G1 Therapeutics [GTHX] share price is $7.15. The Score for GTHX is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
- GTHX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
22
Verrica Pharmaceuticals (VRCA)
is a Sell
Is Verrica Pharmaceuticals a Buy, Sell or Hold?
- The current Verrica Pharmaceuticals [VRCA] share price is $1.81. The Score for VRCA is 22, which is 56% below its historic median score of 50, and infers higher risk than normal.
- VRCA is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
GTHX Stock Price Chart
What is G1 Therapeutics's stock price today?
-
The G1 Therapeutics share price today is $7.15
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and GTHX is experiencing slight buying pressure.
VRCA Stock Price Chart
What is Verrica Pharmaceuticals's stock price today?
-
The Verrica Pharmaceuticals share price today is $1.81
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and VRCA is experiencing selling pressure, which indicates risk of future bearish movement.
GTHX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.34 | Buy |
Relative Strength Index (14 RSI): | 84.39 | Buy |
Chaikin Money Flow: | 0 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (7.1 - 7.14) | Buy |
Bollinger Bands (100): | (2.83 - 6.37) | Buy |
VRCA Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.64 | Sell |
Relative Strength Index (14 RSI): | 25.08 | Sell |
Chaikin Money Flow: | -423096 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (1.88 - 2.66) | Sell |
Bollinger Bands (100): | (3.65 - 8.75) | Sell |
GTHX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 7.14 | Buy |
20-day SMA: | 7.13 | Buy |
50-day SMA: | 5.75 | Buy |
200-day SMA: | 4.06 | Buy |
8-day EMA: | 7.14 | Buy |
20-day EMA: | 6.96 | Buy |
50-day EMA: | 6.03 | Buy |
200-day EMA: | 4.37 | Buy |
VRCA Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 1.89 | Sell |
20-day SMA: | 2.12 | Sell |
50-day SMA: | 4.32 | Sell |
200-day SMA: | 5.97 | Sell |
8-day EMA: | 1.91 | Sell |
20-day EMA: | 2.33 | Sell |
50-day EMA: | 3.8 | Sell |
200-day EMA: | 5.49 | Sell |
G1 Therapeutics Earnings Growth & GTHX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.26 per share, an increase next quarter of $0.08 per share, an increase this year of $0.54 per share, and an increase next year of $0.40 per share.
Verrica Pharmaceuticals Earnings Growth & VRCA Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.09 per share, and an increase next year of $0.68 per share.
G1 Therapeutics Technical Analysis
Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Verrica Pharmaceuticals Technical Analysis
Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |